The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Structural and Signaling Requirements for BCR-ABL-Mediated Transformation and Inhibition of Apoptosis
Open accessAbstract
BCR-ABL is a deregulated tyrosine kinase expressed in Philadelphia chromosome-positive human leukemias. Prolongation of hematopoietic cell survival by inhibition of apoptosis has been proposed to be an integral component of BCR-ABL-induced chronic myelogenous leukemia. BCR-ABL elicits transformation of both fibroblast and hematopoietic cells and blocks apoptosis following cytokine deprivation in various factor-dependent cells. To elucidate the mechanisms whereby BCR-ABL induces transformation and blocks apoptosis in hematopoietic cells, we examined the biological effects of expression of a series of BCR-ABL mutants. Single amino acid substitutions in the GRB2 binding site (Y177F), Src homology 2 domain (R552L), or an autophosphorylation site in the tyrosine kinase domain (Y793F) do not diminish the antiapoptotic and transforming properties of BCR-ABL in hematopoietic cells, although these mutations were previously shown to drastically reduce the transforming activity of BCR-ABL in fibroblasts. A BCR-ABL molecule containing all three mutations (Y177F/R552L/Y793F) exhibits a severe decrease in transforming and antiapoptotic activities compared with the wild-type BCR-ABL protein in 32D myeloid progenitor cells. Ras is activated, the SHC adapter protein is tyrosine phosphorylated and binds GRB2, and myc mRNA levels are increased following expression of all kinase active BCR-ABL proteins with the exception of the Y177F/R552L/Y793F BCR-ABL mutant in 32D cells. We propose that BCR-ABL uses multiple pathways to activate Ras in hematopoietic cells and that this activation is necessary for the transforming and antiapoptotic activities of BCR-ABL. However, Ras activation is not sufficient for BCR-ABL-mediated transformation. A BCR-ABL deletion mutant (delta 176-427) that activates Ras and blocks apoptosis but has severely impaired transforming ability in 32D cells has been identified. These data suggest that BCR-ABL requires additional signaling components to elicit tumorigenic growth which are distinct from those required to block apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Mechanisms and Functions of Cell Death
Ellis, R. E., Yuan, J., & Horvitz, H. R. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003311 · Cited by 2,057
Features of apoptotic cells measured by flow cytometry
Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., & Traganos, F. (1992) · Cytometry · doi:10.1002/cyto.990130802 · Cited by 1,883
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Grignani, F., Pawson, T., & Giuseppe Pelicci, P. (1992) · Cell · doi:10.1016/0092-8674(92)90536-l · Cited by 1,326
Apoptosis in cancer therapy: Crossing the threshold
Fisher, D. E. (1994) · Cell · doi:10.1016/0092-8674(94)90518-5 · Cited by 1,315
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., & Bowtell, D. (1993) · Nature · doi:10.1038/363083a0 · Cited by 1,009
p53-Dependent apoptosis suppresses tumor growth and progression in vivo
Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., & Van Dyke, T. (1994) · Cell · doi:10.1016/0092-8674(94)90534-7 · Cited by 880 · cited 1×
“Deregulation of apoptosis is important in the initiation and progression of many cancers (15, 21, 53, 56).”
BackgroundAskew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867
Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Backer, J. M., Ullrich, A., & White, M. F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05842.x · Cited by 694
Palacios, R., & Steinmetz, M. (1985) · Cell · doi:10.1016/s0092-8674(85)80053-2 · Cited by 688
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 672
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Self-citationDaley, G. Q., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9312 · Cited by 572
A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.
Li, W., Nishimura, R., Kashishian, A., Batzer, A. G., Kim, W. J., Cooper, J. A., & Schlessinger, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.509 · Cited by 481
McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K., Green, D., & Cotter, T. (1994) · Blood · doi:10.1182/blood.v83.5.1179.1179 · Cited by 472
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 420
Dominant negative MYC blocks transformation by ABL oncogenes
Sawyers, C. L., Callahan, W., & Witte, O. N. (1992) · Cell · doi:10.1016/0092-8674(92)90241-4 · Cited by 397
Muller, A. J., Young, J. C., Pendergast, A. M., Pondel, M., Landau, N. R., Littman, D. R., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.4.1785 · Cited by 377
Self-citationThe role of c-myc in cell growth
Evan, G. I., & Littlewood, T. D. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80339-9 · Cited by 365
Pendergast, A. M., Muller, A. J., Havlik, M. H., Maru, Y., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90148-r · Cited by 364
Self-citationSato, N., Sakamaki, K., Terada, N., Arai, K., & Miyajima, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06102.x · Cited by 356
Valtieri, M., Tweardy, D. J., Caracciolo, D., Johnson, K., Mavilio, F., Altmann, S., Santoli, D., & Rovera, G. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3829 · Cited by 348
McWhirter, J. R., & Wang, J. Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05797.x · Cited by 317
Kinoshita, T., Yokota, T., Arai, K., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07000.x · Cited by 298
Control of programmed cell death in normal and leukemic cells: new implications for therapy
Sachs, L., & Lotem, J. (1993) · Blood · doi:10.1182/blood.v82.1.15.bloodjournal82115 · Cited by 284
The BCR gene encodes a novel serine/threonine kinase activity within a single exon
Maru, Y., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90521-y · Cited by 264
Chromosomal Translocations In Lymphoid Malignancies Reveal Novel Proto-Oncogenes
Korsmeyer, S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.785 · Cited by 258
Shibuya, H., Yoneyama, M., Ninomiya-Tsuji, J., Matsumoto, K., & Taniguchi, T. (1992) · Cell · doi:10.1016/0092-8674(92)90533-i · Cited by 231
Association of the Protein Kinases c-Bcr and Bcr-Abl with Proteins of the 14-3-3 Family
Reuther, G. W., Fu, H., Cripe, L. D., Collier, R. J., & Pendergast, A. M. (1994) · Science · doi:10.1126/science.7939633 · Cited by 229
Self-citationInterleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents.
Collins, M. K., Marvel, J., Malde, P., & Lopez-Rivas, A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1043 · Cited by 214
Differential Complementation of Bcr-Abl Point Mutants with c-Myc
Afar, D. E. H., Goga, A., McLaughlin, J., Witte, O. N., & Sawyers, C. L. (1994) · Science · doi:10.1126/science.8153630 · Cited by 184
Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia
ten Hoeve, J., Arlinghaus, R., Guo, J., Heisterkamp, N., & Groffen, J. (1994) · Blood · doi:10.1182/blood.v84.6.1731.1731 · Cited by 183
Involvement of She in Insulin- and Epidermal Growth Factor-Induced Activation of p21ras
Pronk, G. J., De Vries-Smits, A. M. M., Buday, L., Downward, J., Maassen, J. A., Medema, R. H., & Bos, J. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1575-1581.1994 · Cited by 170
Rescue from programmed cell death in leukemic and normal myeloid cells
Lotem, J., Cragoe, E. J., & Sachs, L. (1991) · Blood · doi:10.1182/blood.v78.4.953.953 · Cited by 158
Matsuguchi, T., Salgia, R., Hallek, M. J., Eder, M., Druker, B. J., Ernst, T. J., & Griffin, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37647-0 · Cited by 149
The control of apoptosis in mammalian cells
Collins, M. K., & López‐Rivas, A. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90042-l · Cited by 135
Cleveland, J. L., Dean, M. C., Rosenberg, N. E., Wang, J. Y. J., & Rapp, U. R. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5685 · Cited by 129
Tauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
Matuoka, K., Shibasaki, F., Shibata, M. S., & Takenawa, T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06021.x · Cited by 127
Pendergast, A. M., Gishizky, M. L., Havlik, M. H., & Witte, O. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1728-1736.1993 · Cited by 122
Self-citationKabarowski, J. H. S., Allen, P. B., & Wiedemann, L. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06934.x · Cited by 109
Satoh, T., Fantl, W. J., Escobedo, J. A., Williams, L. T., & Kaziro, Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3706 · Cited by 98
Askew, D. S., Ihle, J., & Cleveland, J. (1993) · Blood · doi:10.1182/blood.v82.7.2079.2079 · Cited by 68
Carlesso, N., Griffin, J. D., & Druker, B. J. (1994) · PubMed · Cited by 66
Pollack, A. S., & Ciancio, G. (1990) · Methods in cell biology · doi:10.1016/s0091-679x(08)60508-7 · Cited by 58
Laneuville, P., Timm, M., & Hudson, A. T. (1994) · PubMed · Cited by 56
Lotem, J., & Sachs, L. (1990) · Blood · doi:10.1182/blood.v76.7.1315.1315 · Cited by 49
Young, J. C., Gishizky, M. L., & Witte, O. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.2.854 · Cited by 30
v-Raf/v-Myc Synergism in Abrogation of IL-3 Dependence: v-Raf Suppresses Apoptosis
Troppmair, J., Cleveland, J. L., Askew, D. S., & Rapp, U. R. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77633-5_57 · Cited by 26
Cited by
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
The Biology of Chronic Myeloid Leukemia
Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,302
Imatinib Mesylate — A New Oral Targeted Therapy
Savage, D. G., & Antman, K. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmra013339 · Cited by 844
Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3780 · Cited by 755
Self-citationThe biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 592
Metadata
- Authors
- Cortez, D., Kadlec, L., & Pendergast, A. M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1995-10
- Volume
- 15
- Issue
- 10
- Pages
- 5531-5541
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2142618806
- Cited by
- 267
- References
- 53
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.